Company Overview
Carocell Bio Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Tuesday 08 November 2016, so this is a well established company. Carocell Bio Limited has been in business for 9 years and 4 months. The accounts status is total exemption full and the accounts are next due on Monday 31 August 2026.
Registered Address

London Bioscience Innovation Centre (Lbic), 2 Royal College Street, London, NW1 0NH
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameCAROCELL BIO LIMITED
Company Number10469714
Registered Office AddressLondon Bioscience Innovation Centre (Lbic)
 2 Royal College Street
 NW1 0NH
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date08/11/2016
Accounting Reference Date Day30
Accounting Reference Date Month11
Accounts Next Due Date31/08/2026
Accounts Last Made Up Date30/11/2024
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date06/12/2017
Previous Company NameChanged Date
BRIDGE BIOTEC LIMITED14 Aug 2019
BRIDGE BIOTEC THERAPEUTICS LIMITED20 Feb 2017
BRIDGE BIOTECH THERAPEUTICS LIMITED15 Nov 2016
Directors & Members
Michael Davies - Director
(British, 64 years old, born March 1962)
Appointed 08 November 2016
 Active
Deepbridge Ned Limited - Director
Appointed 13 September 2024
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Michael Davies
BLUEBERRY THERAPEUTICS LIMITED
BRIDGE BIOTEC LIMITED
BRIDGE BIOTECH LTD
BRIDGE THERAPEUTICS LTD.
CAROCELL CA LIMITED
FOXHOG VENTURES UK LIMITED
QUODRIUM LIMITED
R&D PHARMA LTD
R&D PHARMACEUTICALS LTD
THERAPEUTIC DEVELOPMENTS (THERADEV) LTD
Deepbridge Ned Limited
ARBNCO LTD
ARTERIUS LIMITED
CHECKBOARD LIMITED
CIRCADA LIMITED
FEN EP LIMITED
FILISIA INTERFACES LTD
FLUORETIQ LIMITED
GREYLIST TRACE LIMITED
HURRICANE MODULAR COMMERCE LIMITED
IBISVISION LIMITED
INAVYA VENTURES LTD
L3M TECHNOLOGIES LIMITED
LCC THERAPEUTICS LTD.
MOLMART LTD.
NEW PATH MOLECULAR RESEARCH LTD
PLASMA FRESH LIMITED
SCHOOL WELLBEING ACCELERATOR LTD
SMALLSPARK SPACE SYSTEMS LIMITED
TRIGENEX LTD
VIDEREGEN LIMITED
VOXSMART LIMITED
Balance Sheet Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Balance Sheet
Fixed Assets 19,728 19,728 19,753
Current Assets 207,361 207,361 169,495
Creditors Due Within One Year 19,042 19,042 13,487
Working Cap 188,319 188,319 156,008
Total Assets Less Current Liabilities 208,047 208,047 175,761
Long-term Liabilities 338,762 338,762 279,650
Net Assets -130,715 -130,715 -103,889
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds -130,715 -130,715 -103,889
Common Size Financial Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Tangible Fixed Assets - - -
Fixed Assets 8.7% 8.7% 10.4%
Stocks Inventory - - -
Debtors 58.7% 58.7% 4.6%
Cash Bank In Hand 32.6% 32.6% 85.0%
Current Assets 91.3% 91.3% 89.6%
Creditors Due Within One Year 8.4% 8.4% 7.1%
Net Current Assets Liabilities 82.9% 82.9% 82.4%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds -57.6% -57.6% -54.9%
Capital Employed - - -
Total Assets Less Current Liabilities 91.6% 91.6% 92.9%
Financial Ratio Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Liquidity Ratio 10.9 10.9 12.6
Solvency Ratio 0.6 0.6 0.6
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Assets 227,089 227,089 189,248
Debt 357,804 357,804 293,137
Net Assets/Debt -130,715 -130,715 -103,889

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around NW1 0NH
CONVENTION ASSOCIATES LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR DIAGNOSTICS LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR SERVICES LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR THERAPEUTICS LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR LIMITED
THE LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
ABACO CAPITAL PLC
Rsm Restructuring Advisory Llp Central Square 5th Floor, 29 Wellington Street, Leeds, NW1 0NH
LEUCID BIO LTD
BUILDING 1000 BEACH DRIVE, WATERBEACH, CAMBRIDGE, NW1 0NH
BIO2BUSINESS LIMITED
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
BUGS BIOSCIENCE LIMITED
2 ROYAL COLLEGE STREET, LONDON BIOSCIENCE INNOVATION CENTRE, LONDON, NW1 0NH
DELTADOT LIMITED
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
Document Filings
Confirmation statement made on 7 November 2025 with updates
Change of details for Dr Michael John Davies as a person with significant control on 15 August 2025
Resolutions
Statement of capital following an allotment of shares on 24 February 2025
Resolutions
Statement of capital following an allotment of shares on 23 December 2024
Resolutions
Statement of capital following an allotment of shares on 6 December 2024
Resolutions
Statement of capital following an allotment of shares on 11 November 2024
Confirmation statement made on 7 November 2024 with updates
Appointment of Deepbridge Ned Limited as a director on 13 September 2024
Resolutions
Statement of capital following an allotment of shares on 24 June 2024
Registered office address changed from , London Bioscience Innovation Centre (Lbic) 2 Royal College Street, London, NW1 0NH, England to London Bioscience Innovation Centre (Lbic) 2 Royal College Street London NW1 0NH on 26 March 2024
Registered office address changed from , Brooks Drive Cheadle Royal Business Park, Cheadle, SK8 3TD, England to London Bioscience Innovation Centre (Lbic) 2 Royal College Street, London, England, NW1 0NH on 25 March 2024
Resolutions
Statement of capital following an allotment of shares on 11 January 2024
Resolutions
Statement of capital following an allotment of shares on 16 November 2023
Confirmation statement made on 7 November 2023 with updates
Resolutions
Statement of capital following an allotment of shares on 30 August 2023
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free